BACKGROUND CONTEXT While reimbursement is centered on 90-day outcomes, some patients persevere through these short-term, transient complications and manage to still achieve optimal, long-term outcomes. PURPOSE Assess whether achieving optimal alignment suffering similar perioperative complications compared to suboptimally-aligned peers are inhibited from reaching long-term clinical success and better cost-utility. STUDY DESIGN/SETTING Retrospective cohort study of a prospective adult spinal deformity (ASD) database. PATIENT SAMPLE A total of 1,541 patients. OUTCOME MEASURES Cost-per-QALY, radiographic realignment, clinical outcomes. METHODS Operative ASD pts with 2Y data were included. Optimal radiographic outcome was defined by SRS-Schwab low deformity in PI-LL, matched in T1PA and being aligned in PI-based PT at 6 weeks. After stratifying pts based on meeting optimal outcome, multivariate analysis controlling for baseline demographics was used to determine significance for complications and hospital-acquired conditions (HACs; DVT/PE, UTI, deep/superficial infection). Calculated Cost per QALY for each time point by 2Y. RESULTS There were 917 ASD pts included. Regarding approach, 69% posterior approach, 31% combined. Groups: 131 were "optimal" (O) and 786 were "not optimal" (NO). Means comparison tests revealed significant differences in age, BMI, but not gender or frailty. The NO group had fewer osteotomies and a lower Invasiveness Index. Analysis of perioperative complications showed that the O group suffered equivocal perioperative complications (58.0% vs 52.2% in the NO group; p=.173) and rates of HACs (9.0% vs. 8.9%, p=.810). Analysis of long-term complications showed that patients in the NO group suffered more major neurological (p=.015) and major mechanical complications (p=.025), and more reoperations (28.7% vs 19.9%; p=.037). When controlling for baseline deformity, age, BMI and frailty, Optimal Outcome patients more often met Best Clinical Outcome (21.5% vs. 11.7%, p=.002). Cost-utility adjusted analysis with determined no difference in the two groups by 6 weeks and 6 months. However, the O group generated significantly better cost-utility by one year, which maintained lower Costs per QALY (p=.005) at two years in favor of the O group. CONCLUSIONS Despite incurring equivocal perioperative complications, patients who met our optimal outcome criteria experienced significantly less mechanical complications and reoperations by 2 years, leading to a better long-term cost-utility overall. Accordingly, a higher, transient perioperative complication profile should not preclude surgical correction and future policy efforts should place more consideration on the long-term for outcome measures in adult spinal deformity surgery. FDA DEVICE/DRUG STATUS This abstract does not discuss or include any applicable devices or drugs. While reimbursement is centered on 90-day outcomes, some patients persevere through these short-term, transient complications and manage to still achieve optimal, long-term outcomes. Assess whether achieving optimal alignment suffering similar perioperative complications compared to suboptimally-aligned peers are inhibited from reaching long-term clinical success and better cost-utility. Retrospective cohort study of a prospective adult spinal deformity (ASD) database. A total of 1,541 patients. Cost-per-QALY, radiographic realignment, clinical outcomes. Operative ASD pts with 2Y data were included. Optimal radiographic outcome was defined by SRS-Schwab low deformity in PI-LL, matched in T1PA and being aligned in PI-based PT at 6 weeks. After stratifying pts based on meeting optimal outcome, multivariate analysis controlling for baseline demographics was used to determine significance for complications and hospital-acquired conditions (HACs; DVT/PE, UTI, deep/superficial infection). Calculated Cost per QALY for each time point by 2Y. There were 917 ASD pts included. Regarding approach, 69% posterior approach, 31% combined. Groups: 131 were "optimal" (O) and 786 were "not optimal" (NO). Means comparison tests revealed significant differences in age, BMI, but not gender or frailty. The NO group had fewer osteotomies and a lower Invasiveness Index. Analysis of perioperative complications showed that the O group suffered equivocal perioperative complications (58.0% vs 52.2% in the NO group; p=.173) and rates of HACs (9.0% vs. 8.9%, p=.810). Analysis of long-term complications showed that patients in the NO group suffered more major neurological (p=.015) and major mechanical complications (p=.025), and more reoperations (28.7% vs 19.9%; p=.037). When controlling for baseline deformity, age, BMI and frailty, Optimal Outcome patients more often met Best Clinical Outcome (21.5% vs. 11.7%, p=.002). Cost-utility adjusted analysis with determined no difference in the two groups by 6 weeks and 6 months. However, the O group generated significantly better cost-utility by one year, which maintained lower Costs per QALY (p=.005) at two years in favor of the O group. Despite incurring equivocal perioperative complications, patients who met our optimal outcome criteria experienced significantly less mechanical complications and reoperations by 2 years, leading to a better long-term cost-utility overall. Accordingly, a higher, transient perioperative complication profile should not preclude surgical correction and future policy efforts should place more consideration on the long-term for outcome measures in adult spinal deformity surgery.